[144] Cellebrite DI Ltd. SEC Filing
Cellebrite DI Ltd. (CLBT) filed a Form 144, reporting a proposed resale of 1,045 vested Restricted Share Units under an S-8 registered plan with a vesting date of May 11, 2026. The filing also detailed recent open-market sales by Marcus Jewell in February 2026, involving 1,779, 13,276, and 4,613 ordinary shares. This is a routine notice for planned employee or affiliate dispositions and has a neutral impact on the market.
How this was made
The 30-second read
Why it matters
The filing is unlikely to influence investor sentiment significantly; it reflects normal insider trading practices.
Market read
The news has minimal impact on the stock's trading dynamics, primarily relevant for compliance and insider trading transparency.
What to watch
Potential for future disclosures or market reactions unrelated to this filing should be monitored.
Background
Cellebrite DI Ltd. filed a Form 144 indicating routine insider share sales and a resale of vested RSUs, which is common corporate activity.
Ticker impact
The filing pertains to insider share dispositions and does not indicate significant corporate changes.
Minimal to no immediate price movement expected
Insider sales and planned dispositions are common and typically priced in, especially when volume is modest and routine.
Market effects
No significant sector-wide implications
Limited regional impact
Negligible
Counterpoint
Some traders might interpret insider sales as a potential signal of upcoming company concerns, but evidence here suggests routine activity.
Key entities
- CompanyCellebrite DI Ltd.
A provider of digital intelligence solutions.





